Galbiati F, Razani B, Lisanti MP. Caveolae and caveolin-3 in muscular dystrophy[J]. Trends Mol Med, 2008, 7（10）：435-441.
[2]
Scherer PE, Lewis RY, Volonte D, et al. Cell-type and tissue-specific expression of caveolin-2：Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo[J]. J Biol Chem, 1997, 272（46）：29337-29346.
[3]
Zhu Z, Li Y, Li K, et al. Molecular characterization and expression analysis of the porcine Caveolin-3 gene[J]. Biochem Biophys Res Commun, 2003, 346（1）：7-13.
[4]
Le Lay S, Kurzchalia TV. Getting rid of caveolins：phenotypes of caveolin-deficient animals[J]. Biochim Biophys Acta, 2005, 1746（3）：322-332.
[5]
Carlson BM, Carlson JA, Dedkov EI, et al. Concentration of caveolin-3 at the neuro-muscular junction in young and old rat skeletal muscle fibers[J]. J Histochem Cytochem, 2003, 51（9）：1113-1118.
[6]
Vistisen B, Roepstorff K, Roepstorff C, et al. Sarcolemmal FAT/CD36 in human skeletal muscle coloealizes with caveolin-3 and is more abundant in type 1 than in type2 fibers[J]. J LiPid Res, 2004, 45（4）：603-609.
[7]
Song KS, Scherer PE, Tang Z, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins[J]. J Biol Chem, 1996, 271（25）：15160-15165.
[8]
Galbiati F, Engelman JA, Vloonte D, et al. Caveolin-3 null mice show a loss of caveolae, changes in the mierodomain distribution of the dystrophin-glyeoprotein complex, and T-tubule abnormalities[J]. Biol Chem, 2001, 276：21425-21433.
Qian LL. The research progress in caveolae and caveolin-3[J]. Foreign Medical Sciences：Molecular Biology, 2002, 24：100-102.
[11]
John H, Chidlow J, William C. Caveolae, caveolins, and cavins：complex control of cellular signaling and inflammation[J]. Cardiovasc Res, 2010, 86（2）：219-225.
[12]
Fanzanifa A, Musaro A, Stoppani E, et al. Hypertrophy and atrophy inversely regulate caveolin-3 expression in myoblasts[J]. Biochem Biophys Res Commun, 2007, 357（1）：314-318.
[13]
Shin DH, Kim JS, Kwon BS, et al. Caveolin-3 expression during early chicken development[J]. Brain Res Dev Brain Res, 2003, 141（1-2）：83-89.
[14]
Kerzer HA, Schaart G, Tandon NN, et al. Subcellular immunolocalisation of fatty acid translocase（FAT）/CD36 in human type-1 and type-2 skeletal muscle fibres[J]. Histochem Cell Biol, 2004, 121（2）：101-107.
[15]
Murbartian J, Arisa JM, Edward PR. Funetional impact of alternative splicing of human T-type Cav3. 3 calcium channels[J]. NeuroPhysiol, 2004, 92：3399-3407.
Minetti C, Schlegel A, Scherer P, et al. Impairment of caveolae formation and T-system disorganization in human museular dystrophy with caveolin-3 defieieney[J]. Am J Pathol, 2002, 160（1）：265-270.
[20]
Parton RG, Way M, Zorzi N, et al. Caveolin-3 associates with developing T-tubules during muscles differentiation[J]. J Cell Biol, 1997, 136：137-154.
